4-(2-Methoxyethoxy)-N-(3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyrimidin-2-amine

Catalog No. :
ACFMQD616
CAS No. :
1312535-40-2
Molecular Formula :
C20H28BN3O4
Molecular Weight :
385.27

IUPAC Name:4-(2-methoxyethoxy)-N-(3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyrimidin-2-amine

4-(2-Methoxyethoxy)-N-(3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyrimidin-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(2-Methoxyethoxy)-N-(3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyrimidin-2-amine
IUPAC Name4-(2-methoxyethoxy)-N-(3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyrimidin-2-amine
MDL No.MFCD28953701
Molecular FormulaC20H28BN3O4
Molecular Weight385.27
SMILESCC1(C)C(C)(C)OB(C2=CC(C)=CC(NC3=NC=CC(OCCOC)=N3)=C2)O1
InChI KeyCYRBDFAKRZGLAP-UHFFFAOYSA-N
Synonym4-(2-Methoxyethoxy)-N-[3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan- 2-yl)phenyl]pyrimidin-2-amine;2-Pyrimidinamine, 4-(2-methoxyethoxy)-N-[3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-
CAS No.1312535-40-2

Synthetic Route by SureRoute

1. ACFMQD616 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGAMC829 route compound structure diagram
    ACGAMC8291312535-18-4 In Stock
  4. Then
  5. ACFMQD616 route product structure diagram
    ACFMQD6161312535-40-2
Inquiry

2. ACFMQD616 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFMQD616 route product structure diagram
    ACFMQD6161312535-40-2
Inquiry

Comments (0)